Pulmonx
LUNG
101 hedge funds and large institutions have $1.26B invested in Pulmonx in 2020 Q4 according to their latest regulatory filings, with 101 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
51.6% more ownership
Funds ownership: 0% → 51.6% (+52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$55.3M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$54M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53.8M |
| 4 |
BlackRock
New York
|
+$41.7M |
| 5 |
Primecap Management
Pasadena,
California
|
+$35.9M |
Top Sellers
LUNG Hedge Fund Activity: Q4 2020 in Review
101 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2020, worth a combined $1.26B.
Buyers outnumbered sellers: 101 funds opened new LUNG positions and 0 closed out — a net gain of 101 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $55.3M.
- 101 institutional investors held Pulmonx (LUNG) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $1.26B of Pulmonx stock for Q4 2020.
- 101 funds opened new Pulmonx positions in Q4 2020 and 0 closed out, a net change of +101 holders.
- The largest Pulmonx buyer in Q4 2020 was RTW Investments, an estimated $55.3M added.
Based on aggregated 13F filings for Q4 2020.